activin

  1. SNT Gatchaman

    Diminished vasculogenesis under inflammatory conditions is mediated by Activin A, 2023, Manohar-Sindhu et al.

    Diminished vasculogenesis under inflammatory conditions is mediated by Activin A Manohar-Sindhu, Sahana; Merfeld-Clauss, Stephanie; Goddard, Yana; March, Keith L.; Traktuev, Dmitry O. Severe inflammatory stress often leads to vessel rarefaction and fibrosis, resulting in limited tissue...
  2. SNT Gatchaman

    The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis, 2021, Kimber-Trojnar et al.

    The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis Kimber-Trojnar, Żaneta; Pilszyk, Aleksandra; Niebrzydowska, Magdalena; Pilszyk, Zuzanna; Ruszała, Monika; Leszczyńska-Gorzelak, Bożena Endometriosis is a disease that affects women of...
  3. SNT Gatchaman

    EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies, 2023, Williams et al.

    EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies Williams, Marshall V.; Mena-Palomo, Irene; Cox, Brandon; Ariza, Maria Eugenia There is increasing evidence that put into question the classical dogma that the Epstein–Barr virus (EBV)...
  4. Andy

    EBV/HHV-6A dUTPases contribute to ME/CFS pathophysiology by enhancing TFH cell differentiation and extrafollicular activities, 2022, Cox et al

    Full title: EBV/HHV-6A dUTPases contribute to Myalgic Encephalomyelitis/Chronic-Fatigue-Syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a chronic, debilitating multisystem illness of...
  5. Sly Saint

    Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), 2021, Gravelsina et al

    Abstract Reliable serum biomarkers are of immense need for diagnostic purposes of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—a disabling and complex disease for which diagnosis is mainly based on clinical symptoms. The aim of this study was to evaluate a possible diagnostic...
  6. John Mac

    Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning & Utility of Activin B for Defining Symptom Severity (2019) Lidbury et al.

    https://www.mdpi.com/2075-4418/9/3/79
  7. Hutan

    Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis, 2017, Lidbury et al

    https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1161-4 Background Investigations of activin family proteins as serum biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). CFS/ME is a disease with complex, wide-ranging symptoms, featuring...
  8. Sly Saint

    Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection

    Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection Alice M. RichardsonEmail author, Don P. Lewis, Badia Kita, Helen Ludlow, Nigel P. Groome, Mark P. Hedger, David M. de Kretser and Brett A. Lidbury...
Back
Top Bottom